Related Experiment Videos

The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*

R H Chapman1, C P Ferrufino, S L Kowal

  • 1US Health Economics and Outcomes Research, IMS Health, Falls Church, VA 22046, USA. RChapman@us.imshealth.com

Insights

Improving adherence to cardiovascular medications requires cost-effective interventions. This review found that while more expensive interventions like case management are more effective, simpler methods like reminders are less costly, guiding future program design.

Area of Science:

  • Cardiovascular medicine
  • Health economics
  • Behavioral science

Background:

  • Poor adherence to cardiovascular medications is a significant public health issue.
  • Interventions to improve medication adherence are widely proposed but often lack comprehensive cost-effectiveness analysis.
  • Understanding the relationship between intervention costs and effectiveness is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To review the effectiveness and associated costs of various interventions designed to improve adherence to cardiovascular disease therapies.
  • To update previous reviews by incorporating recent studies on adherence interventions.
  • To provide data to guide the selection and implementation of cost-effective adherence programs.

Main Methods:

  • A systematic review of MEDLINE was conducted, updating a prior review with studies published between July 2002 and October 2007.
  • Eligible studies compared at least one intervention against a control group, used objective adherence measures, and followed patients for at least six months.
  • Effectiveness was quantified as relative improvement (RI), and costs were calculated and adjusted to 2007 US dollars for a six-month period.

Main Results:

  • The review identified 23 interventions from 18 studies, with relative improvements in adherence ranging from 1.11 to 4.65.
  • Six-month intervention costs varied significantly, from $10 to $142 per patient.
  • Reminder interventions were least effective (RI: 1.11-1.14) but most cost-effective ($10/6 months), while case management was most effective (RI: 1.23-4.65) but most expensive ($90-$130/6 months).

Conclusions:

  • A positive association generally exists between the cost of adherence interventions and their effectiveness.
  • The findings suggest that a balance between cost and effectiveness should guide the design and implementation of cardiovascular medication adherence programs.
  • Considering both the benefits to adherence and the associated costs is essential for developing successful interventions.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.